Remove 2010 Remove Competition Remove Physicians
article thumbnail

Comparison of Humira biosimilars in the US and Europe

Pharmaceutical Technology

Biosimilars are an important tool to facilitate competition, lower the price of drugs, and create savings across the board. Until 2010, no regulatory approval pathway for biosimilars existed in the US and the first biosimilar was only approved in the US in 2015. The biosimilar market in the US may progress differently this time.

article thumbnail

Top 10 Best Telemedicine Companies in the USA

Medico Reach

Physicians and patients continue to have a very positive opinion of the organization. Amwell Headquarters: Massachusetts, Boston Revenue: $30M Employee Size: 800 employees Website URL: [link] The two american brothers who are the physicians founded the Amwell, formerly known as American Well.

Doctors 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Market with Maximum Efficiency by Obeying Your Inner Sensei

PM360

This article will explore how life sciences marketers can increase their competitive advantage by applying the discipline’s basic principles to their own strategies. In terms of branding, this judo principle lies at the nexus of three interrelated concepts: market research, competitive analysis, and brand positioning.

article thumbnail

Fixed-dose combination: Considerations for design, formulation, manufacturing and analysis

Pharmaceutical Technology

Understanding both the significant competitive advantages that FDC products can offer, and the difficulties and potential pitfalls associated with development and manufacturing of FDC drugs in oral solid dosage forms is a critical first step for companies exploring this approach. Of those 131 approved FDCs, 98 were oral dosage forms.

article thumbnail

How AI Can Help Medical Science Liaisons Juggle Their Ever-Growing Responsibilities

PM360

1 And, on average , the FDA approved 60% more drugs between 2010-2019 than the yearly average over the previous decade. In fact, the pharmaceutical industry’s development pipeline has reached an all-time high of 20,109 products under active development at the end of January 2022, an increase of 500 from 2021.

article thumbnail

How retailers and “payviders” are disrupting U.S. healthcare in 2024

Clarivate

Humana is following a similar growth strategy as it sharpens competition with UnitedHealthcare in the Medicare Advantage sector. Signify’s healthcare platform also assists 65,000 provider partners to participate in value-based care with nearly 1 million attributed lives Oak Street Health acquisition May 2023 CVS acquired Oak Street for $10.6

Retail 52
article thumbnail

The cluster effect: Connectivity and collaboration in life sciences hubs

Pharmaceutical Technology

The Charleston area currently has a regional workforce of 30,000, including 2,000-plus physicians. In addition, between 2010 and 2019, Charleston’s workforce has grown three times faster than the US average and twice as fast as South Carolina’s average. Attracting many of these recent investments is the area’s impressive talent pool.

Medical 52